Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Blood and Transplant
203 Longmead Rd, Avon
Bristol
BS16 7FG
UK
Person cyswllt: Tennille Madigan
Ffôn: +44 7795483583
E-bost: tennille.madigan@nhsbt.nhs.uk
NUTS: UKK12
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.nhsbt.nhs.uk
Cyfeiriad proffil y prynwr: https://www.nhsbt.nhs.uk
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Malaria & Arbovirus detection assays
II.1.2) Prif god CPV
71900000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 1.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
71900000
33141625
33124130
33696200
II.2.3) Man cyflawni
Cod NUTS:
UKK12
Prif safle neu fan cyflawni:
NHS Blood and Transplant Site: Filton
II.2.4) Disgrifiad o’r caffaeliad
The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. Kit Evaluation Group (KEG) approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024. <br/>Please email tennille.madigan@nhsbt.nhs.uk for further information and expressions of interest by 30th April 2024.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
01/07/2024
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section VI: Gwybodaeth ategol
VI.5) Dyddiad anfon yr hysbysiad hwn
29/02/2024